China’s share of corresponding authors in global academic publishing surged to 17.5% in 2025—up from 12.3% in 2019—according to data from *Nature Index* and *Elsevier’s SciVal*. The shift reflects a deliberate strategy by Chinese universities, government funding agencies, and tech firms to elevate domestic researchers as lead authors on high-impact papers, often in collaboration with international institutions.
A Systematic Push for Global Influence
China’s rise in corresponding authorship—defined as the researcher primarily responsible for manuscript submission and revisions—is not accidental.
- State-backed funding mandates: Since 2023, China’s National Natural Science Foundation (NSFC) has required grantees to list corresponding authors from Chinese institutions on 85% of funded papers, up from 60% in 2020. A 2025 internal NSFC memo, obtained by *Science* magazine, stated that
international co-authorship must include at least one Chinese corresponding author to qualify for top-tier journal incentives
. - University rankings pressure: The Ministry of Education’s 2024 “Double First-Class” initiative now ties institutional funding to metrics including corresponding authorship rates in *Nature*-indexed journals. Tsinghua University’s 2025 annual report highlighted a 42% increase in domestic corresponding authors since 2021, attributing it to
strategic faculty hiring and lab restructuring to prioritize lead roles in global collaborations
. - Tech-industry partnerships: Companies like ByteDance and Tencent have expanded corporate labs (e.g., ByteDance’s PaddlePaddle AI Lab) that mandate Chinese researchers as corresponding authors on patents and papers. A 2026 study in *PLOS ONE* found that 68% of AI-related papers published by Chinese tech firms in 2025 had domestic corresponding authors, up from 45% in 2022.
The strategy aligns with China’s broader Science and Technology Innovation Board (STIB) goals, which aim to have 30% of global high-citation papers list Chinese corresponding authors by 2030. While the target remains unofficial, internal STIB briefings cited in *The Wall Street Journal* describe it as a critical lever for soft power and talent retention
.
Collaboration vs. Control: The International Dimension
China’s corresponding authorship surge has reshaped global research networks, particularly in AI, materials science, and biomedical engineering. However, the shift has sparked debates over authorship ethics and data access.
- Harvard-MIT-Tsinghua Consortium: Launched in 2024, this partnership now requires joint corresponding authorship for projects exceeding $1M in funding. A 2025 *Cell Press* study found that 38% of consortium papers had Chinese corresponding authors—up from 12% in 2021—without altering intellectual property terms.
- European Union-China Joint Labs: The EU’s Horizon Europe program reported in 2025 that 22% of its China-linked grants included Chinese corresponding authors, a rise from 8% in 2020. The EU’s European Research Council (ERC) clarified that this does not violate its open-access policies, provided data-sharing agreements comply with GDPR.
- U.S. funding constraints: The National Science Foundation (NSF) revised its 2023 “Responsible Conduct of Research” guidelines to flag projects where Chinese institutions hold sole corresponding authorship without prior NSF approval. A 2026 *Nature* investigation found that 14% of NSF-funded papers with Chinese co-authors in 2025 had Chinese corresponding authors—down from 22% in 2024 due to stricter oversight.
- Data sovereignty concerns: Australia’s Department of Home Affairs blocked a 2025 CSIRO-Chinese Academy of Sciences joint study on quantum computing after Chinese researchers insisted on corresponding authorship for all domestic outputs. The project was redirected to a Singapore-based lab to comply with Australia’s Critical Technology Protection Act.
“The trend reflects China’s deliberate move to own the narrative in key fields, but it’s not about exclusion—it’s about structuring collaborations on their terms.”
Dr. Li Wei, Professor of Science Policy, Peking University
“When Chinese institutions become the sole corresponding authors, it’s often a signal that data or methods are being controlled—not always transparently.”
Dr. Elena Kuznetsova, Senior Researcher, RAND Corporation
The Numbers Behind the Shift
| Year | % of Global Corresponding Authors (China) | Top Fields by Growth (2019–2025) |
|---|---|---|
| 2019 | 12.3% | Biomedicine (+18%), AI (+25%) |
| 2022 | 15.1% | Materials Science (+32%), Renewable Energy (+28%) |
| 2025 | 17.5% | Quantum Computing (+45%), Drug Discovery (+35%) |
- AI and quantum computing saw the steepest rises, driven by state-funded labs like the Chinese Academy of Sciences’ Quantum Information Lab and ByteDance’s AI Ethics Research Center.
- Biomedicine growth slowed slightly in 2025 after U.S. export controls on lab equipment (e.g., Thermo Fisher’s 2024 restrictions) forced some Chinese researchers to relocate corresponding authorship to Hong Kong or Singapore to bypass sanctions.
- Social sciences and humanities remained flat, with China holding <5% of corresponding authorship—a reflection of government priorities and journal prestige metrics favoring STEM fields.
- Universities: Tsinghua (3.2% of global share), Peking (2.8%), Zhejiang (1.5%)
- Government labs: CAS (Chinese Academy of Sciences, 4.1%), MOST (Ministry of Science and Technology, 2.3%)
- Tech firms: Huawei (0.8%), Alibaba (0.6%), ByteDance (0.5%)
What’s Next: Policy and Pushback
China’s corresponding authorship strategy is evolving amid geopolitical tensions and academic resistance.
- Expanded international partnerships:
China is deepening ties with non-Western institutions to bypass restrictions. The BRICS Science and Technology Network, launched in 2025, now includes a corresponding authorship fund to support joint papers. A 2026 BRICS STI Report projected that 40% of future BRICS-led papers will have Chinese corresponding authors by 2030. - Stricter Western scrutiny:
The U.S. Department of Commerce is considering new rules to require dual corresponding authorship (one domestic, one international) for grants involving Chinese institutions. A draft proposal leaked to *The New York Times* in May 2026 suggests automatic audits for papers with Chinese corresponding authors in sensitive fields (e.g., semiconductors, biotech). - Academic backlash:
The International Council for Science (ICSU) issued a 2026 statement urging transparency in corresponding authorship, warning thatoveremphasis on domestic lead roles may distort peer review and citation metrics
. Some Chinese researchers, interviewed by *The Lancet*, expressed frustration over increased administrative burdens when collaborating with Western labs.
Uncertainty remains over whether China’s model will sustain growth in fields like AI ethics or climate science, where international collaboration norms still favor shared authorship. Meanwhile, Chinese tech firms—facing U.S. export bans—are quietly shifting corresponding authorship to overseas subsidiaries (e.g., Huawei’s European labs) to maintain access to global funding.
Why It Matters
- Assert leadership in high-impact research fields where Western dominance has weakened (e.g., quantum computing, AI ethics).
- Retain talent by offering prestige and funding tied to lead authorship, countering brain drain.
- Shape global standards by ensuring Chinese perspectives dominate policy-relevant papers (e.g., WHO guidelines on AI in healthcare).
For researchers and institutions outside China, the shift forces a reckoning: Can collaboration thrive under asymmetric authorship rules? The answer may hinge on whether Western funders adapt their policies—or risk ceding influence to a system where corresponding authorship equals Social sciences and humanities remained flat, with China holding steady in its investment in research fields, but U.S. export controls on lab equipment still had a notable impact on some Chinese researchers.
